Gemtuzumab and bronchopulmonary aspergillosis Patient Reports February 09, 2010

Gemtuzumab Side Effects Report #5170548-3
Gemtuzumab side effect was reported by a Consumer or non-health professional from GERMANY on Nov 27, 2006. Male patient, 73 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: bronchopulmonary aspergillosis, fungal infection , pneumonia viral. Gemtuzumab dosage: 12 MG. Patient was hospitalized. Patient recovered.

Gemtuzumab Side Effects Report #4985081-9
Gemtuzumab side effect was reported by a Consumer or non-health professional from GERMANY on Apr 11, 2006. Male patient, 73 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: bronchopulmonary aspergillosis, fungal infection . Gemtuzumab dosage: 12 MG. Patient was hospitalized. Patient recovered.

Gemtuzumab Side Effects Report #5429701-3
Gemtuzumab side effect was reported by a Physician from BELGIUM on Aug 22, 2007. Male patient, 72 years of age, weighting 163.1 lb, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: bronchopulmonary aspergillosis, fluid retention, hyperbilirubinaemia, pancytopenia, shock haemorrhagic, venoocclusive disease. Gemtuzumab dosage: 11.6 MG. During the same period patient was treated with GEMTUZUMAB OZOGAMICIN. Patient was hospitalized. Patient died on 03/21/2005.

Gemtuzumab Side Effects Report #5434258-7
Gemtuzumab side effect was reported by a Physician from BELGIUM on Aug 28, 2007. Male patient, 72 years of age, weighting 163.1 lb, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: bronchopulmonary aspergillosis, fluid retention, hyperbilirubinaemia, pancytopenia, shock haemorrhagic, venoocclusive liver disease. Gemtuzumab dosage: 11.6 MG. During the same period patient was treated with GEMTUZUMAB OZOGAMICIN. Patient was hospitalized. Patient died on 03/21/2005.


Gemtuzumab Side Effects Report #4688359-1
Gemtuzumab side effect was reported by a Consumer or non-health professional from on June 01, 2005. Male patient, 72 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: ascites, bronchopulmonary aspergillosis, fluid retention, hepatic congestion, hepatic steatosis, hepatomegaly, hepatotoxicity, hyperbilirubinaemia, lung disorder. Gemtuzumab dosage: 11.6 MG. During the same period patient was treated with GEMTUZUMAB OZOGAMICIN. Patient was hospitalized. Patient died.

Gemtuzumab Side Effects Report #4869677-0
Gemtuzumab side effect was reported by a Consumer or non-health professional from FRANCE on Dec 20, 2005. Male patient, 70 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, bronchopulmonary aspergillosis, malignant neoplasm progression. Gemtuzumab dosage: unknown. Patient died.

Gemtuzumab Side Effects Report #4875726-6
Gemtuzumab side effect was reported by a Consumer or non-health professional from FRANCE on Jan 02, 2006. Male patient, 70 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, bronchopulmonary aspergillosis, malignant neoplasm progression. Gemtuzumab dosage: unknown. Patient died.

Gemtuzumab Side Effects Report #4972941-8
Gemtuzumab side effect was reported by a Consumer or non-health professional from GERMANY on Mar 29, 2006. Male patient, 67 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: bronchopulmonary aspergillosis, septic shock. Gemtuzumab dosage: 12 MG. During the same period patient was treated with CYTARABINE, ETOPOSIDE, NOVANTRON. Patient was hospitalized. Patient died.

Gemtuzumab Side Effects Report #5043603-6
Gemtuzumab side effect was reported by a Consumer or non-health professional from GERMANY on June 16, 2006. Male patient, 67 years of age, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: bronchopulmonary aspergillosis, septic shock. Gemtuzumab dosage: 12 MG. During the same period patient was treated with CYTARABINE, ETOPOSIDE, NOVANTRONE. Patient was hospitalized. Patient recovered.


Gemtuzumab Side Effects Report #5907973-6
Gemtuzumab side effect was reported by a Physician from CANADA on Oct 01, 2008. Male patient, 59 years of age, weighting 266.5 lb, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: bronchopulmonary aspergillosis, respiratory failure. Gemtuzumab dosage: TOTAL DOSE ADMINISTERED THIS COURSE WAS 14.6 MG. During the same period patient was treated with DAUNORUBICIN, CYTARABINE. Patient was hospitalized. Patient died on 09/26/2008.

Gemtuzumab Side Effects Report #5291103-0
Gemtuzumab side effect was reported by a Physician from BELGIUM on Apr 04, 2007. Male patient, weighting 163.1 lb, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: bronchopulmonary aspergillosis, fluid retention, hyperbilirubinaemia, pancytopenia, shock haemorrhagic. Gemtuzumab dosage: 11.6 MG. During the same period patient was treated with GEMTUZUMAB OZOGAMICIN. Patient was hospitalized. Patient died on 03/21/2005.

Gemtuzumab Side Effects Report #5292219-5
Gemtuzumab side effect was reported by a Physician from BELGIUM on Apr 04, 2007. Male patient, weighting 163.1 lb, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: bronchopulmonary aspergillosis, fluid retention, hyperbilirubinaemia, pancytopenia, shock haemorrhagic. Gemtuzumab dosage: 11.6 MG. During the same period patient was treated with GEMTUZUMAB OZOGAMICIN. Patient was hospitalized. Patient died on 03/21/2005.

Gemtuzumab Side Effects Report #5294845-6
Gemtuzumab side effect was reported by a Physician from BELGIUM on Apr 10, 2007. Female patient, weighting 125.7 lb, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: bronchopulmonary aspergillosis, capillary leak syndrome, cardiac failure, neutropenia. Gemtuzumab dosage: unknown. During the same period patient was treated with GEMTUZUMAB OZOGAMICIN, TARGOCID, TOBRACIN, DIFLUCAN. Patient died on 03/22/2006.

Gemtuzumab Side Effects Report #5519868-0
Gemtuzumab side effect was reported by a Physician from BELGIUM on Nov 14, 2007. Female patient, weighting 125.7 lb, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: bronchopulmonary aspergillosis, capillary leak syndrome, cardiac failure, neutropenia. Gemtuzumab dosage: unknown. During the same period patient was treated with GEMTUZUMAB OZOGAMICIN, TARGOCID, TOBRACIN, DIFLUCAN. Patient died on 03/22/2006.


Gemtuzumab Side Effects Report #5928542-8
Gemtuzumab side effect was reported by a Physician from BELGIUM on Oct 21, 2008. Female patient, weighting 125.7 lb, was diagnosed with acute myeloid leukaemia and was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: bronchopulmonary aspergillosis, capillary leak syndrome, cardiac failure, neutropenia. Gemtuzumab dosage: unknown. During the same period patient was treated with GEMTUZUMAB OZOGAMICIN, TARGOCID, TOBRACIN, DIFLUCAN. Patient died on 03/22/2006.

Gemtuzumab Side Effects Report #5902132-5
Gemtuzumab side effect was reported by a Physician from FRANCE on Sept 25, 2008. Male patient, weighting 110.2 lb, was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: bronchopulmonary aspergillosis, candida sepsis, cardiac failure acute, escherichia sepsis, hepatic failure, respiratory distress. Gemtuzumab dosage: 3 MG/M^2 TOTAL DAILY. During the same period patient was treated with GEMTUZUMAB OZOGAMICIN, GEMTUZUMAB OZOGAMICIN, ARACYTINE, DAUNORUBICIN HYDROCHLORIDE. Patient was hospitalized. Patient died on 09/28/2008.

Gemtuzumab Side Effects Report #5950556-2
Gemtuzumab side effect was reported by a Physician from FRANCE on Nov 07, 2008. Male patient, weighting 110.2 lb, was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: acute respiratory failure, bronchopulmonary aspergillosis, candida sepsis, cardiac failure acute, escherichia sepsis, hepatic failure, respiratory distress. Gemtuzumab dosage: 3 MG/M^2 TOTAL DAILY. During the same period patient was treated with GEMTUZUMAB OZOGAMICIN, GEMTUZUMAB OZOGAMICIN, CYTARABINE, DAUNORUBICIN. Patient was hospitalized. Patient died on 09/28/2008.

Gemtuzumab Side Effects Report #5953146-0
Gemtuzumab side effect was reported by a Physician from FRANCE on Nov 07, 2008. Male patient, weighting 110.2 lb, was treated with Gemtuzumab. After drug was administered, patient experienced the following side effects: bronchopulmonary aspergillosis, candida sepsis, cardiac failure acute, escherichia sepsis, hepatic failure, respiratory distress. Gemtuzumab dosage: 3 MG/M^2 TOTAL DAILY. During the same period patient was treated with GEMTUZUMAB OZOGAMICIN, GEMTUZUMAB OZOGAMICIN, CYTARABINE, DAUNORUBICIN. Patient was hospitalized. Patient died on 09/28/2008.